Viewing Study NCT05121350

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 4:45 PM

Ignite Modification Date: 2025-12-25 @ 2:32 PM

Study NCT ID: NCT05121350

Status: UNKNOWN

Last Update Posted: 2022-02-18

First Post: 2021-11-15

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module